14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AVRO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for AVROBIO Inc
(Updated on Apr 24, 2024)

Sell candidate since Apr 05, 2024 Loss -6.30% PDF

The AVROBIO Inc stock price fell by -1.65% on the last day (Wednesday, 24th Apr 2024) from $1.21 to $1.19. During the last trading day the stock fluctuated 2.11% from a day low at $1.19 to a day high of $1.21. The price has fallen in 4 of the last 10 days and is down by -4.8% for this period. Volume has increased on the last day by 287 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 340 thousand shares were bought and sold for approximately $404.99 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.33% during the next 3 months and, with a 90% probability hold a price between $1.02 and $1.23 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AVRO Signals & Forecast

There are few to no technical positive signals at the moment. The AVROBIO Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.22 and $1.27. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -11.19%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). AVROBIO Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for AVROBIO Inc stock

AVROBIO Inc finds support from accumulated volume at $1.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.0250 (2.11%) between high and low. For the last week, the stock has had daily average volatility of 3.19%.

AVROBIO Inc is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AVRO) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect AVROBIO Inc to open at $1.20, and during the day (based on 14 day Average True Range), to move between $1.14 and $1.24, which gives a possible trading interval of +/-$0.0475 (+/-3.99%) up or down from last closing price. If AVROBIO Inc takes out the full calculated possible swing range there will be an estimated 7.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.15 (3.36%) than the resistance at $1.26 (5.88%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is AVROBIO Inc stock A Buy?

AVROBIO Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.077 Sell Candidate Unchanged

Predicted Opening Price for AVROBIO Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.20 ( 0.420%) $1.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AVRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.22 2.52 %
R2 1.21 1.72 %
R1 1.20 1.22 %
Current price: 1.19
Support S1 1.19 -0.382 %
S2 1.18 -0.88 %
S3 1.17 -1.68 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.31 10.08 %
R2 1.30 9.24 %
R1 1.26 5.88 %
Current price 1.19
Support S1 1.15 -3.36%
S2 0 .
S3 0 .

FAQ

What is the symbol for AVROBIO Inc Stock and on which exchange is it traded?
The symbol for AVROBIO Inc is AVRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AVROBIO Inc Stock?
AVROBIO Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy AVROBIO Inc Stock?
AVROBIO Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AVROBIO Inc Stock.

What's the current price of AVROBIO Inc Stock?
As of the end of day on the Apr 24, 2024, the price of an AVROBIO Inc (AVRO) share was $1.19.

What is the 52-week high and low for AVROBIO Inc Stock?
The 52-week high for AVROBIO Inc Stock is $1.70 and the 52-week low is $0.570.

What is the market capitalization of AVROBIO Inc Stock?
As of the Apr 24, 2024, the market capitalization of AVROBIO Inc is 53.384M.

When is the next earnings date for AVROBIO Inc?
The upcoming earnings date for AVROBIO Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About AVROBIO Inc

AVROBIO AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry di... AVRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT